Dr. Truty is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2166Fax+1 507-284-5196
Summary
- Surgical Oncology - Expertise in Pancreatic Cancer, Liver Cancer, Bile Duct Tumors, Gallbladder Cancer, Carcinoid and Neuroendocrine Tumors, Gastric Cancer, Sarcomas, and Intestinal Cancers. Specializing in advanced cancers (deemed unresectable/inoperable elsewhere). Willing to provide free-of-charge 2nd opinions and records review so patients can get definitive and honest answers on the appropriate treatment of their tumors.
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2009 - 2012
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Surgery, 2002 - 2009
- Chicago Medical SchoolMSc, Pathology, 1999 - 2002
- Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2002
- Chicago Medical SchoolMSc, Physiology, 1998 - 1999
- University of ChicagoBA, Biological Sciences, 1991 - 1995
Certifications & Licensure
- MN State Medical License 2003 - 2025
- TX State Medical License 2009 - 2013
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 38 citationsPrognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience.Zhaohui Jin, Mindy L. Hartgers, Cristobal T. Sanhueza, Christopher R. Shubert, Steven R. Alberts
European Journal of Surgical Oncology. 2018-02-16 - 3 citationsTyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeutic Target in Pancreatic Cancer.Santosh Renuse, Vijay Sagar Madamsetty, Dong-Gi Mun, Anil K. Madugundu, Smrita Singh
Cancers. 2021-07-07 - 7 citationsMolecular Peritoneal Staging for Pancreatic Ductal Adenocarcinoma Using Mutant KRAS Droplet-Digital Polymerase Chain Reaction: Results of a Prospective Clinical TrialJennifer A. Yonkus, Roberto Alva-Ruiz, Amro M. Abdelrahman, Jennifer L. Leiting, Amber Schneider
Journal of the American College of Surgeons. 2021-07-01
Authored Content
- Indications and Perioperative Outcomes for Pancreatectomy with Arterial ResectionMay 2018
Press Mentions
- ‘My Life Is in the Right Hands.’ Surgery Gives California Woman Hope After Cancer DiagnosisMarch 5th, 2023
- Mayo Clinic to Lead New Radiotracer Trial for Detecting Pancreatic CancerJanuary 30th, 2023
- People with Pancreatic Cancer Are Living Longer, Thanks to Improved ApproachesNovember 30th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: